Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Erin M. McLoughlin"'
Publikováno v:
Journal of Thoracic Oncology. 14:e269-e271
Autor:
Kathlene DeGregory, Jeremy M Sen, Michael K Keng, Steven P. Dunn, Meredith K Mort, Erin M. McLoughlin, Mohammad Abuannadi, Amy L. Morris, Joseph F. Mort
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:680-687
Background Acute myeloid leukemia patients receive anthracycline-containing induction chemotherapy. Anthracyclines cause cardiotoxicity; however, there is a paucity of data reflecting the risk of cardiotoxicity in the acute myeloid leukemia populatio
Autor:
Erin M. McLoughlin, Ryan D. Gentzler
Publikováno v:
Thoracic surgery clinics. 30(2)
Up to 20% of lung adenocarcinomas in the United States and Europe and 50% in Asia have activating mutations of the tyrosine kinase domain of the epidermal growth factor receptor (EGFR). The identification and subsequent targeting of mutations with EG
Autor:
Edward B. Stelow, Erin M. McLoughlin, James M. Larner, Kevin Brady, Michael P. Bergman, Ryan D. Gentzler, Alia C. Lynch, Ralph Sumner Abraham
Publikováno v:
Journal of Thoracic Oncology. 14:e193-e195
Publikováno v:
Journal of Thoracic Oncology. 14:S659-S660
Autor:
Jeanne Giordano, Michael K Keng, Jeremy M Sen, Erin M. McLoughlin, Louise Man, Amy Morris, Lisa Huntsinger, Kathlene DeGregory, Tanya Thomas, Elizabeth Daniels
Publikováno v:
Journal of oncology practice. 15(8)
There are no national standards for time between patient arrival and the initiation of scheduled chemotherapy (time to chemotherapy [TTC]). Delays in this process have a negative impact on patient care and the use of health care resources. At the Uni
Publikováno v:
Journal of Thoracic Oncology. 14:S738
Autor:
Anna Baccei, Tan A. Ince, Mark D. Fleming, Katelyn E. Gagne, Rebecca L. Zon, Erin M. McLoughlin, Odelya Hartung, Ellis J. Neufeld, Paul H. Lerou, George Q. Daley, Suneet Agarwal, Anne Cherry, Bryan L. Gorman, Justine D. Miller, Jin Zhang
Publikováno v:
Stem Cells. 31:1287-1297
In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas
Autor:
Anke K. Bergmann, Mark D. Fleming, Dean R. Campagna, Suneet Agarwal, Sylvia S. Bottomley, Ellis J. Neufeld, Erin M. McLoughlin
Publikováno v:
Pediatric Blood & Cancer. 54:273-278
Background Sideroblastic anemias are heterogeneous congenital and acquired bone marrow disorders characterized by pathologic iron deposits in mitochondria of erythroid precursors. Among the congenital sideroblastic anemias (CSAs), the most common for
Autor:
Erin M. McLoughlin, Louise Ming-Wai Man, Jeremy M Sen, Tanya Thomas, Kathlene DeGregory, Elizabeth Daniels, Jeanne Cahan, Lisa Huntsinger, Michael Kenneth Keng
Publikováno v:
Journal of Clinical Oncology. 35:96-96
96 Background: Patients with established cancer diagnoses often experience delays in starting scheduled inpatient chemotherapy (CTX) after arrival on the University of Virginia (UVA) Medical Center oncology unit. These delays negatively impact hospit